Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028)
Status:
Completed
Trial end date:
2007-03-02
Target enrollment:
Participant gender:
Summary
The objective of the trial was to show equivalence in recovery from neuromuscular block after
a single dose of 4.0 mg/kg sugammadex, administered at first twitch (T1) 3-10% after
continuous infusion of rocuronium, between participants receiving maintenance anesthesia
using propofol and participants receiving sevoflurane, to investigate the safety and to
compare the plasma levels of rocuronium in participants after continuous infusion of
rocuronium and before the administration of sugammadex, under either propofol or sevoflurane
anesthesia.